Clinical Research
Discover our extraordinary innovation and success across multiple therapeutic areas.

Our oncology program targets the role of inflammatory pathways in cancer progression. Results from our Phase 1/2 study suggest a potential breakthrough treatment for advanced pancreatic cancer.

LimeRiver is investigating the role of inflammation in neurological disorders, with a focus on conditions where the innate immune system contributes to disease progression.

Our Natrunix program in rheumatoid arthritis represents a novel approach to treating autoimmune inflammation using True Human™ antibodies.

Leveraging natural human immunity to develop next-generation treatments for infectious diseases, harnessing the power of antibodies naturally produced by immune donors.